humana inc. - HUM

HUM

Close Chg Chg %
259.08 -2.91 -1.12%

Open Market

256.17

-2.91 (1.12%)

Volume: 617.46K

Last Updated:

Dec 31, 2025, 3:59 PM EDT

Company Overview: humana inc. - HUM

HUM Key Data

Open

$258.26

Day Range

256.11 - 261.63

52 Week Range

206.87 - 315.35

Market Cap

$30.81B

Shares Outstanding

120.27M

Public Float

N/A

Beta

0.46

Rev. Per Employee

N/A

P/E Ratio

24.28

EPS

$10.70

Yield

136.65%

Dividend

$0.89

EX-DIVIDEND DATE

Dec 26, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

1.38M

 

HUM Performance

1 Week
 
-1.04%
 
1 Month
 
4.22%
 
3 Months
 
-9.72%
 
1 Year
 
0.95%
 
5 Years
 
-37.57%
 

HUM Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 29
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 284.375
Number of Ratings 29 Current Quarters Estimate 10.637
FY Report Date 03 / 2026 Current Year's Estimate 12.289
Last Quarter’s Earnings -4.03 Median PE on CY Estimate N/A
Year Ago Earnings 17.06 Next Fiscal Year Estimate 19.499
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 22 22 27 23
Mean Estimate 10.64 5.25 12.29 19.50
High Estimates 13.10 5.95 14.41 24.10
Low Estimate 6.23 3.32 8.74 14.30
Coefficient of Variance 15.16 11.16 11.29 10.59

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 7 6 6
OVERWEIGHT 3 3 3
HOLD 18 17 19
UNDERWEIGHT 0 0 0
SELL 1 1 0
MEAN Overweight Hold Overweight

Insider Actions for Humana Inc. - HUM

Date Name Shares Transaction Value
Dec 18, 2025 Jim Rechtin President & CEO 27,102 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $270.16 per share 7,321,876.32
Dec 18, 2025 Sanjay K. Shetty President, CenterWell 10,678 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $270.16 per share 2,884,768.48
Dec 18, 2025 Sanjay K. Shetty President, CenterWell 11,566 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Dec 18, 2025 Japan A. Mehta Chief Information Officer 8,628 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Dec 18, 2025 Michelle A. O'Hara Chief Human Resources Officer 10,634 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $270.16 per share 2,872,881.44
Dec 18, 2025 Michelle A. O'Hara Chief Human Resources Officer 11,266 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Dec 18, 2025 Japan A. Mehta Chief Information Officer 8,158 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $270.16 per share 2,203,965.28
Dec 18, 2025 David E. Dintenfass President, Enterprise Growth 15,316 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $270.16 per share 4,137,770.56
Dec 18, 2025 Jim Rechtin President & CEO 30,474 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Dec 18, 2025 Sanjay K. Shetty President, CenterWell 10,986 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Dec 18, 2025 Sanjay K. Shetty President, CenterWell 10,847 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $270.16 per share 2,930,425.52
Dec 18, 2025 Sanjay K. Shetty President, CenterWell N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Dec 18, 2025 David E. Dintenfass President, Enterprise Growth 16,234 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Dec 18, 2025 Celeste Mellet Brown Chief Financial Officer 28,454 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $270.16 per share 7,687,132.64
Dec 18, 2025 Celeste Mellet Brown Chief Financial Officer 29,676 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 3, 2025 Kurt J. Hilzinger Director 14,645 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 3, 2025 David T. Feinberg Director 493 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 3, 2025 Gordon A. Smith Director 118 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 1, 2025 George Renaudin President, Insurance 170 Other acquisition or disposition 0.00
Feb 26, 2025 Vishal Agrawal Chief Strat & Corp Dev Officer 13,447 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $258.58 per share 3,477,125.26

Humana Inc. in the News